In recent years, there has been increased scrutiny of specific post-operative metrics by hospital administrators and payers. Surgeons have been asked to minimize hospital length of stay, readmission rates, and post-operative complications for their patients for both quality and financial reasons. Enhanced Recovery After Surgery (ERAS) programs, whose ultimate goal is expedited recovery of patients, has implications for these issues. ERAS relies on interdisciplinary coordination that optimizes patient nutrition, antibiotic prophylaxis, thromboprophylaxis, and pain control, amongst other factors, through standardized and evidence-based care pathways to achieve early mobilization and faster recovery. Importantly, these protocols utilize multimodal analgesia strategies to minimize opioid use. These strategies have obvious implications for patient safety and quality improvement as well as for addressing our national opioid crisis. This panel discussion will focus on informing otolaryngologists about the emerging literature on ERAS in otolaryngology-head and neck surgery, with opioid-sparing multimodal analgesia as an essential component. Speakers will describe the benefits of ERAS and strategies for the enactment into practice for otolaryngology patients, with discussion of both head and neck surgery-specific protocols and programs that include all otolaryngology subspecialties. Furthermore, discussion will include the methods for monitoring compliance and outcomes. Audience members will have the opportunity to choose specific ERAS interventions for further discussion.